跳至主要内容
临床试验/CTRI/2025/10/095753
CTRI/2025/10/095753招募中4 期

A prospective multicenter post marketing observational study to evaluate the effectiveness of an oral multivitamin and multimineral supplement also containing amino acids in patients with hair loss telogen effluvium

Abbott Healthcare Private Limited4 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2025年10月20日最近更新:

试验速览

阶段
4 期
状态
招募中
入组人数
200
试验地点
4
主要终点
To evaluate the effectiveness of the treatment with oral nutritional supplements in reducing hair loss at 12 weeks using hair pull test

研究概览

简要总结

This is a prospective multicenter post marketing observational study to evaluate

the effectiveness of an oral multivitamin and multimineral supplement also

containing amino acids in patients with hair loss telogen effluvium with age group

18 to 60 years This multicenter study will enrol approximately 200 patients with

telogen effluvium The patients will be followed up for 3 months after enrolment

The enrolment of patients for the study will be based on the approved protocol by

the local ethics committee All the patients with a clinical diagnosis of telogen

effluvium, meeting all inclusion and none of the exclusion criteria, and ready to

give informed consent for study participation, are eligible for participation in this

observational study The study is planned to be conducted for approximately 12

months.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Male and Female patients aged 18 to 60 years diagnosed with Telogen Effluvium by a dermatologist Willingness and ability to provide informed consent for participation in the study Agreement to comply with the prescribed Follihair AM PM and attend scheduled follow up assessments during the study period.

排除标准

  • Pregnancy or lactation, as hormonal changes during these periods can influence hair health Use of contraceptive medications with known hormonal effects that could affect hair growth Diagnosed with Androgenetic alopecia Concomitant use of drugs that cause hair loss as per dermatologist’ discretion Use of hair growth medications or treatments within the last 6 months, which may confound the study results as per treating dermatologist’s discretion Use of nutritional supplements for hair loss in the last 3 months as per dermatologist’s discretion Any known history of allergies or adverse reactions to the components of the study products- similar products as per dermatologist’s discretion Current participation in other clinical trials involving hair health or dermatological treatments Any other medical conditions that could impact hair health as per dermatologist’s discretion History of major surgical procedures or significant trauma in the last 6 months.

结局指标

主要结局

To evaluate the effectiveness of the treatment with oral nutritional supplements in reducing hair loss at 12 weeks using hair pull test

时间窗: Baseline and 12 weeks

次要结局

  • To evaluate the effectiveness of treatment with oral nutritional(supplements in reducing hair loss at 12 weeks using global assessment score the GAS a 7 point score from minus 3 severe worsening to plus 3 excellent)

研究者

申办方类型
Pharmaceutical industry-Indian
责任方
Principal Investigator
主要研究者

Dr Shehnaz Arsiwala

Renewderm Skin Hair Laser Aesthetics Centre

研究点 (4)

Loading locations...

相似试验